BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17181485)

  • 21. Malignant urachal lesions.
    Sheldon CA; Clayman RV; Gonzalez R; Williams RD; Fraley EE
    J Urol; 1984 Jan; 131(1):1-8. PubMed ID: 6361280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comprehensive review of pediatric urachal anomalies and predictive analysis for adult urachal adenocarcinoma.
    Gleason JM; Bowlin PR; Bagli DJ; Lorenzo AJ; Hassouna T; Koyle MA; Farhat WA
    J Urol; 2015 Feb; 193(2):632-6. PubMed ID: 25219697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined modalities treatment of pulmonary metastasis from an urachal adenocarcinoma.
    Piégay F; Mornex JF
    Rare Tumors; 2013; 5(3):e32. PubMed ID: 24179644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical, prognostic, and therapeutic aspects of urachal carcinoma-A comprehensive review with meta-analysis of 1,010 cases.
    Szarvas T; Módos O; Niedworok C; Reis H; Szendröi A; Szász MA; Nyirády P
    Urol Oncol; 2016 Sep; 34(9):388-98. PubMed ID: 27267737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urachal cancer-current concepts of a rare cancer.
    Reis H; Szarvas T
    Pathologe; 2019 Jun; 40(Suppl 1):31-39. PubMed ID: 30895340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current Understanding of Urachal Adenocarcinoma and Management Strategy.
    Claps M; Stellato M; Zattarin E; Mennitto A; Sepe P; Guadalupi V; Mennitto R; de Braud FGM; Verzoni E; Procopio G
    Curr Oncol Rep; 2020 Jan; 22(1):9. PubMed ID: 31989430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metastatic Urachus Neoplasia: A Case Report and Review of the Current Literature.
    Maish WN; Nguyen LK; Ngu C; Bennett G; Pranavan G
    Clin Genitourin Cancer; 2019 Apr; 17(2):e377-e382. PubMed ID: 30595523
    [No Abstract]   [Full Text] [Related]  

  • 28. Modified FOLFOX6 chemotherapy in patients with metastatic urachal cancer.
    Yanagihara Y; Tanji N; Miura N; Shirato A; Nishimura K; Fukumoto T; Azuma K; Miyauchi Y; Kikugawa T; Yokoyama M
    Chemotherapy; 2013; 59(6):402-6. PubMed ID: 24969043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urachal carcinoma: from gross specimen to morphologic, immunohistochemical, and molecular analysis.
    Riva G; Mian C; Luchini C; Girolami I; Ghimenton C; Cima L; Novelli L; Hanspeter E; Mazzoleni G; Schwienbacher C; Pycha S; D'Elia C; Trenti E; Pycha A; Martignoni G; Hes O; Eccher A; Nesi G; Brunelli M
    Virchows Arch; 2019 Jan; 474(1):13-20. PubMed ID: 30302546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study.
    Balar AV; Castellano D; O'Donnell PH; Grivas P; Vuky J; Powles T; Plimack ER; Hahn NM; de Wit R; Pang L; Savage MJ; Perini RF; Keefe SM; Bajorin D; Bellmunt J
    Lancet Oncol; 2017 Nov; 18(11):1483-1492. PubMed ID: 28967485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.
    Reis H; Krafft U; Niedworok C; Módos O; Herold T; Behrendt M; Al-Ahmadie H; Hadaschik B; Nyirady P; Szarvas T
    Dis Markers; 2018; 2018():7308168. PubMed ID: 29721106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance.
    Módos O; Reis H; Niedworok C; Rübben H; Szendröi A; Szász MA; Tímár J; Baghy K; Kovalszky I; Golabek T; Chlosta P; Okon K; Peyronnet B; Mathieu R; Shariat SF; Hollósi P; Nyirády P; Szarvas T
    Oncotarget; 2016 Jun; 7(26):39293-39301. PubMed ID: 27283768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urachal carcinoma: a pathologic and clinical study of 46 cases.
    Dhillon J; Liang Y; Kamat AM; Siefker-Radtke A; Dinney CP; Czerniak B; Guo CC
    Hum Pathol; 2015 Dec; 46(12):1808-14. PubMed ID: 26364859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metastatic urachal cancer responding to FOLFOX chemotherapy.
    Tran B; McKendrick J
    Can J Urol; 2010 Apr; 17(2):5120-3. PubMed ID: 20398453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcome of urachal cancer in Japanese patients.
    Hayashi T; Yuasa T; Uehara S; Inoue Y; Yamamoto S; Masuda H; Fujii Y; Fukui I; Yonese J
    Int J Clin Oncol; 2016 Feb; 21(1):133-8. PubMed ID: 26138265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Management of a Case With Mucin-Producing Adenocarcinoma Originating From the Urachus.
    Angelopoulos P; Kapsalos-Dedes S; Manolitsis I; Katsimperis S; Bellos T; Kyriazis I; Neofytou P; Tzelves L; Berdempes M; Skolarikos A
    Cureus; 2024 Jan; 16(1):e52376. PubMed ID: 38361714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urachal Adenocarcinoma: a Case Report and Review of the Literature.
    Chejara R; Goyal S; Choudhary S; Shah S
    Indian J Surg Oncol; 2023 Sep; 14(3):677-681. PubMed ID: 37900644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of mucosal-associated lymphoid tissue lymphoma of the urachus.
    Tsuboi K; Bekku K; Haisa K; Kajihara Y; Tsugawa T; Inoue Y; Sako T; Murao W; Ebara S
    IJU Case Rep; 2023 Jul; 6(4):253-256. PubMed ID: 37405026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival of Patients With UrAC and Primary BAC and Urothelial Carcinoma With Glandular Differentiation.
    Wang T; Lv Z; Feng H; Li J; Cui B; Yang Y; Huang X; Zhang X; Li X; Ma X
    Front Oncol; 2022; 12():860133. PubMed ID: 35646691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atypical Presentation of a Urachal Carcinoma as an Enterocutaneous Fistula.
    Martins AR; Frazão J; Nogueira S; Godinho A
    Cureus; 2022 Mar; 14(3):e23697. PubMed ID: 35505719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.